Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas
暂无分享,去创建一个
K. Tarte | T. Fest | E. Flécher | C. Pangault | F. Guilloton | F. Mourcin | M. Latour | P. Amé-Thomas | P. Sok | Murielle Grégoire | Patricia Amé-Thomas
[1] A. Maseri,et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps , 2014, Journal of thrombosis and haemostasis : JTH.
[2] Burkhard Ludewig,et al. B cell homeostasis and follicle confines are governed by fibroblastic reticular cells , 2014, Nature Immunology.
[3] Daniel Öhlund,et al. Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.
[4] M. I. Crespo,et al. Neutrophils Exhibit Differential Requirements for Homing Molecules in Their Lymphatic and Blood Trafficking into Draining Lymph Nodes , 2014, The Journal of Immunology.
[5] R. Gascoyne,et al. The tumour microenvironment in B cell lymphomas , 2014, Nature Reviews Cancer.
[6] X. Yuan,et al. The IL-6–STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression , 2014, Cell Death and Disease.
[7] S. Pileri,et al. Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma. , 2014, Blood.
[8] K. Tarte,et al. COX-2–Independent Effects of Celecoxib Sensitize Lymphoma B Cells to TRAIL-Mediated Apoptosis , 2014, Clinical Cancer Research.
[9] T. K. van den Berg,et al. Failure To Detect Functional Neutrophil B Helper Cells in the Human Spleen , 2014, PloS one.
[10] S. Serrano,et al. Correction: Corrigendum: B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen , 2014, Nature Immunology.
[11] C. Klein,et al. Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab. , 2013, Blood.
[12] D. Jeoung,et al. Human follicular dendritic cells promote germinal center B cell survival by providing prostaglandins. , 2013, Molecular immunology.
[13] K. Tarte,et al. Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells , 2012, Haematologica.
[14] K. Tarte,et al. Stromal Cell Contribution to Human Follicular Lymphoma Pathogenesis , 2012, Front. Immun..
[15] Dong-hee Kim,et al. Differential effect of CCL2 on constitutive neutrophil apoptosis between normal and asthmatic subjects , 2012, Journal of cellular physiology.
[16] R. Mebius,et al. Interdependence of stromal and immune cells for lymph node function. , 2012, Trends in immunology.
[17] S. Lang,et al. A novel p38‐MAPK signaling axis modulates neutrophil biology in head and neck cancer , 2012, Journal of leukocyte biology.
[18] K. Tarte,et al. Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes. , 2011, Blood.
[19] A. Challa,et al. ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process , 2011, Annals of the rheumatic diseases.
[20] A. Kater,et al. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas. , 2011, Blood.
[21] G. Pizzolo,et al. Toll‐Like Receptor‐3‐Activated Human Mesenchymal Stromal Cells Significantly Prolong the Survival and Function of Neutrophils , 2011, Stem cells.
[22] Xiao‐Yu Yin,et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. , 2011, Journal of hepatology.
[23] A. Chevailler,et al. CCR7 is involved in the migration of neutrophils to lymph nodes. , 2011, Blood.
[24] F. Berrino,et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. , 2010, Blood.
[25] T. Habermann,et al. Predicting survival for diffuse large B‐cell lymphoma patients using baseline neutrophil/lymphocyte ratio , 2010, American journal of hematology.
[26] Pierre Tattevin,et al. Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock. , 2010, The Journal of infectious diseases.
[27] L. Pasqualucci,et al. Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma , 2009, Nature.
[28] J. Cerhan,et al. A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. , 2009, Blood.
[29] L. Staudt,et al. Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.
[30] F. Bazzoni,et al. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils. , 2008, Immunology letters.
[31] F. Montecucco,et al. Human Mesenchymal Stem Cells Inhibit Neutrophil Apoptosis: A Model for Neutrophil Preservation in the Bone Marrow Niche , 2008, Stem cells.
[32] W. Fridman,et al. Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation , 2007, Journal of leukocyte biology.
[33] K. Tarte,et al. Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. , 2007, Blood.
[34] L. Staudt,et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.
[35] T. Hara,et al. Lymph Node Fibroblastic Reticular Cells Construct the Stromal Reticulum via Contact with Lymphocytes , 2004, The Journal of experimental medicine.
[36] M. Czuczman,et al. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] J. Baars,et al. Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy , 2003, Leukemia.
[38] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[39] M. Colombo,et al. Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma. , 2014, Cancer discovery.
[40] K. Tarte,et al. Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling , 2012, Leukemia.
[41] J. Tao,et al. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis , 2009, Leukemia.
[42] J. Tschopp,et al. Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. , 2007, Blood.
[43] Juan F. García,et al. The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma. , 2006, Haematologica.
[44] L. Ivashkiv,et al. IFN-gamma-primed macrophages exhibit increased CCR2-dependent migration and altered IFN-gamma responses mediated by Stat1. , 2005, Journal of immunology.
[45] L. Staudt,et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.